Kalaris Therapeutics, Inc 10-Q for FY2022 Q3
Kalaris Therapeutics, Inc. (KLRS)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Kalaris Therapeutics, Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $42.07M
- compared with a net loss of $45.51M a year earlier
- Diluted EPS
- -$0.50
- compared with -$0.72 a year earlier